Formycon AG will develop, register, manufacture and supply the product, while Zydus Lifesciences Global FZE, United Arab Emirates will be responsible for the commercialization of FYB206 in the defined territories
Dr Reddy’s will pay Immutep US$ 20 million upfront and could deliver as much as US$ 349.5 million in regulatory and commercial milestones
MRI is particularly valuable in pediatric care due to its non-invasive nature
Implementing PFAS testing in the early development stages allows medical device manufacturers to prepare for potential regulatory updates
The BlueSeal Horizon 3.0T platform incorporates advanced magnet technology
The platform integrates with CT imaging and uses deep learning models to generate a 3D digital twin of lung anatomy
The MUSE system offers a minimally invasive solution for treating gastroesophageal reflux disease
The update reflects long-term clinical trial data showing that many patients with mCSCC or laCSCC experienced lasting responses
Pfizer and Valneva have been collaborating on VLA15’s development and commercialization since April 2020
The approvals target adult MIBC patients who are ineligible for cisplatin-based chemotherapy
Subscribe To Our Newsletter & Stay Updated
